The Director of External Cooperation and Marketing Department of the Health Innovation Business Unit of the globally renowned biopharmaceutical company Bollinger Ingelheim came to Hangzhou to discuss the cooperation and promotion of stroke rehabilitation projects with ROBO Medical.
Boehringer Ingelheim is a pharmaceutical company dedicated to human biopharmaceutical chemistry. It is the world's largest private pharmaceutical company and an expert in the field of stroke treatment. As a leader in the field of stroke, Berger Ingelheim proposed a "holistic solution for stroke". In 2018, Bollinger Ingelheim brought German rehabilitation concepts and models to China, and successively established Jida Rehabilitation Centers in Shanghai and Chengdu.
The Jiexing lower limb rehabilitation exercise training device developed by ROBO Medical and the Bollinger Ingelheim Jida Yunkang medical software project are both aimed at the home rehabilitation field, and have a high degree of consistency in product strategy collaboration. ROBO Medical will jointly promote the application of new medical technology products in the field of stroke rehabilitation with Bollinger Ingelheim.